Carcinoma of the Esophagus

  • A. M. Mauer


Esophageal cancer is among the ten most frequent cancers in the world [1]. This malignancy displays changing epidemiologic features and tremendous geographic variation. Within the past 3 decades, the incidence of adenocarcinoma of the esophagus and proximal stomach has increased dramatically in the United States and Europe [2, 3, 4, 5, 6].


Squamous Cell Carcinoma Esophageal Cancer Clin Oncol Radiat Oncol Biol Phys Esophageal Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parkin, DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827–841PubMedCrossRefGoogle Scholar
  2. 2.
    Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289PubMedCrossRefGoogle Scholar
  3. 3.
    Hansson LE, Sparen P, Nyren O (1993) Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 54:402–407PubMedCrossRefGoogle Scholar
  4. 4.
    Moller H (1992) Incidence of cancer of oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev 1:159–164PubMedCrossRefGoogle Scholar
  5. 5.
    Powell J, McConkey CC (1990) Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62:440–443PubMedCrossRefGoogle Scholar
  6. 6.
    Tuyns AJ (1992) Oesophageal cancer in France and Switzerland: recent time trends. Eur J Cancer Prev 1:275–278PubMedCrossRefGoogle Scholar
  7. 7.
    Blot WJ (1994) Esophageal cancer trends and risk factors. Semin Oncol 21:403–410PubMedGoogle Scholar
  8. 8.
    Zheng W, Jin F, Devesa SS, Blot WJ, Fraumeni JF Jr, Gao YT (1993) Declining incidence is greater for esophageal than gastric cancer in Shanghai, People’s Republic of China. Br J Cancer 68:978–982PubMedCrossRefGoogle Scholar
  9. 9.
    Sherrill DJ, Grishkin BA, Galal FS, Zajtchuk R, Graeber GM (1984) Radiation-associated malignancies of the esophagus. Cancer 54:726–728PubMedCrossRefGoogle Scholar
  10. 10.
    Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG et al (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87:104–109PubMedCrossRefGoogle Scholar
  11. 11.
    Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr (1995) The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274:474–477PubMedCrossRefGoogle Scholar
  12. 12.
    Kim R, Weissfeld JL, Reynolds JC, Kuller LH (1997) Etiology of Barrett’s metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 6:369–377PubMedGoogle Scholar
  13. 13.
    Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA (1991) p53 gene mutations in Barrett’s epithelium and esophageal cancer. Cancer Res 51:4495–4499PubMedGoogle Scholar
  14. 14.
    Reid BJ, Barrett MT, Galipeau PC, Sanchez CA, Neshat K, Cowan DS, Levine DS (1996) Barrett’s esophagus: ordering the events that lead to cancer. Eur J Cancer Prev 5[Suppl 2]: 57–65PubMedCrossRefGoogle Scholar
  15. 15.
    Rosen N (1994) The molecular basis for cellular transformation: implications for esophageal carcinogensis. Semin Oncol 21:416–424PubMedGoogle Scholar
  16. 16.
    Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T, Wolff G, Hauptmann S, Dorken B, Daniel PT (2001) Analysis of p53/BAX/pl6(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and pl6(ink4a/CDKN2) identifies patients with good prognosis. J Clin Oncol 19: 2272–2281PubMedGoogle Scholar
  17. 17.
    Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Il-son DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV, Meltzer SJ (2000) Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92:1805–1811PubMedCrossRefGoogle Scholar
  18. 18.
    Mukaida H, Toi M, Hirai T, Yamashita Y, Toge T (1991) Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 68: 142–148PubMedCrossRefGoogle Scholar
  19. 19.
    Nakamura T, Nekarda H, Hoelscher AH, Bollschweiler E, Harbeck N, Becker K, Siewert JR, Harbec N (1994) Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett’s esophagus. Cancer 73:1785–1794PubMedCrossRefGoogle Scholar
  20. 20.
    Klimstra DS (1994) Pathologic prognostic factors in esophageal carcinoma. Semin Oncol 21:425–430PubMedGoogle Scholar
  21. 21.
    Daly JM, Karnell LH, Menck HR (1996) National Cancer Data Base report on esophageal carcinoma. Cancer 78: 1820–1828PubMedCrossRefGoogle Scholar
  22. 22.
    Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Gerald GP, O’Sullivan B, Sobin LH, Yarbro JW (1997) AJCC cancer staging manual. Lippincott-Raven, Philadelphia, pp 65–68Google Scholar
  23. 23.
    Lightdale CJ (1994) Staging of esophageal cancer. I. Endoscopic ultrasonography. Semin Oncol 21:438–446PubMedGoogle Scholar
  24. 24.
    Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, Ferson PF, Keenan RJ, Belani CP (1997) Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64:765–769PubMedCrossRefGoogle Scholar
  25. 25.
    O’Brien MG, Fitzgerald EF, Lee G, Crowley M, Shanahan F, O’Sullivan GC (1995) A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol 90:2191–2194Google Scholar
  26. 26.
    Roth JA, Putnam JB Jr (1994) Surgery for cancer of the esophagus. Semin Oncol 21:453–461PubMedGoogle Scholar
  27. 27.
    Ellis FH Jr, Gibb SP, Watkins E Jr (1983) Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg 198:531–540PubMedCrossRefGoogle Scholar
  28. 28.
    Sugimachi K, Maekawa S, Koga Y, Ueo H, Inokuchi K (1986) The quality of life is sustained after operation for carcinoma of the esophagus. Surg Gynecol Obstet 162:544–546PubMedGoogle Scholar
  29. 29.
    Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg 67: 31–540Google Scholar
  30. 30.
    Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984PubMedCrossRefGoogle Scholar
  31. 31.
    Katlic MR, Wilkins EW Jr, Grillo HC (1990) Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 99: 929–938PubMedGoogle Scholar
  32. 32.
    Millikan KW, Silverstein J, Hart V, Blair K, Bines S, Roberts J, Doolas A (1995) A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 130:617–624PubMedCrossRefGoogle Scholar
  33. 33.
    Sugimachi K, Inokuchi K, Kuwano H, Kai H, Okamura T, Okudaira Y (1983) Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus. Surg Gynecol Obstet 157:537–540PubMedGoogle Scholar
  34. 34.
    Van Andel JG, Dees J, Dijkhuis CM, Fokkens W, van Houten H, de Jong PC, van Woerkom-Eykenboom WM (1979) Carcinoma of the esophagus: results of treatment. Ann Surg 190:684–689PubMedCrossRefGoogle Scholar
  35. 35.
    De-Ren S (1989) Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329–334CrossRefGoogle Scholar
  36. 36.
    Beatty JD, DeBoer G, Rider WD (1979) Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure. Cancer 43:2254–2267PubMedCrossRefGoogle Scholar
  37. 37.
    Newaishy GA, Read GA, Duncan W, Kerr GR (1982) Results of radical radiotherapy of squamous cell carcinoma of the oesophagus. Clin Radiol 33:347–352PubMedCrossRefGoogle Scholar
  38. 38.
    Earlam R, Cunha-Melo JR (1980) Oesophogeal squamous cell carcinoma. II. A critical view of radiotherapy. Br J Surg 67:457–461PubMedCrossRefGoogle Scholar
  39. 39.
    Enzinger PC, Ilson DH, Kelsen DP (1999) Chemotherapy in esophageal cancer. Semin Oncol 26:12–20PubMedGoogle Scholar
  40. 40.
    Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP (1994) Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086–1091PubMedCrossRefGoogle Scholar
  41. 41.
    Conroy T, Etienne PL, Adenis A, Wagener DJ, Paillot B, François E, Bedenne L, Jacob JH, Seitz JF, Bleiberg H, Van Pottelsberghe C, Van Glabbeke M, Delgado FM, Merle S, Wils J (1996) Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group. J Clin Oncol 14:164–170PubMedGoogle Scholar
  42. 42.
    Lin L, Hecht JR (2000) A phase II trial of irinotecan in patients with advanced adenocarcinoma of the gastroesophageal (GE) junction (abstract). Proc Am Soc Clin Oncol 19:289AGoogle Scholar
  43. 43.
    Enzinger PC, Kulke MH, Clark JW, Ryan DP, Earle CC, Berg D, Vincitore M, Morgan JA, Grossman SR, Mayer RJ, Fuchs CS (2000) Phase II trial of CPT-11 in previously untreated patients with advanced adenocarcinoma of the esophagus and stomach (abstract). Proc Am Soc Clin Oncol 19:315AGoogle Scholar
  44. 44.
    Mei W, Xian-Zhi G, Weibo Y, Guojun H, Liang-Jun W, Da-Wei Z (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327CrossRefGoogle Scholar
  45. 45.
    Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJL, Mackillop WJ (1992) Low-dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113PubMedCrossRefGoogle Scholar
  46. 46.
    Launois B, Delarue D, Campion JP, Kerbaol M (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153:690–692PubMedGoogle Scholar
  47. 47.
    Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Dalesio O, Buyse M, Duez N (1988) The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC. Rec Res Cancer Res 110:1–13CrossRefGoogle Scholar
  48. 48.
    Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, Mantyla M, Modig H, Munck-Wikland E, Rosengren B, Tausjo J, Eigen K (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104–1109PubMedCrossRefGoogle Scholar
  49. 49.
    Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Favre JP, Dalesio O, Buyse M, Duez N (1987) The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11:426–432PubMedCrossRefGoogle Scholar
  50. 50.
    Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B, Nygaard K, Parmar MK, Roussel A, Spiliopoulos G, Stewart LA, Tierney JF, Mei W, Rugang Z (1998) Preoperative radiotherapy in esophageal carcinoma: a metaanalysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 41: 579–583PubMedCrossRefGoogle Scholar
  51. 51.
    Teniere P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123–130PubMedGoogle Scholar
  52. 52.
    Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113: 138–147PubMedGoogle Scholar
  53. 53.
    Schlag P (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 127:1446–1450PubMedCrossRefGoogle Scholar
  54. 54.
    Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96:242–248PubMedGoogle Scholar
  55. 55.
    Kok TC, von Lanschot J, Sirsman PD, von Overhagen H, Talanus HV (1997) Neoadjuvant chemotherapy in operable esophageal carcinoma: final report of a phase III multicenter randomized controlled trial (abstract). Proc Am Soc Clin Oncol 16:277AGoogle Scholar
  56. 56.
    Clark PI (2000) Medical research council randomised trial of surgery with or without pre-operative chemotherapy in resectable cancer of the oesophagus (MRC Upper GI Tract Cancer Group). Kluwer Academic, Boston (European Society of Medical Oncology 11, Suppl 4)Google Scholar
  57. 57.
    Vokes EE (1993) Interactions of chemotherapy and radiation. Semin Oncol 20:70–79PubMedGoogle Scholar
  58. 58.
    Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, Boutin D, Campion JP, Launois B (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779–1784PubMedCrossRefGoogle Scholar
  59. 59.
    Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Oilier JC, Pavy JJ, Mercier M, Sahmoud T (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167PubMedCrossRefGoogle Scholar
  60. 60.
    Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305–313PubMedGoogle Scholar
  61. 61.
    Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462–467PubMedCrossRefGoogle Scholar
  62. 62.
    Araujo CM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, Pinto LH, Canary PC (1991) A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67:2258–2261PubMedCrossRefGoogle Scholar
  63. 63.
    Slabber CF, Nel JS, Schoeman L, Burger W, Falkson G, Falkson CI (1998) A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 21:462–465PubMedCrossRefGoogle Scholar
  64. 64.
    Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J, Sischy B (1998) domized studyofradiotherapy vs. radiotherapy alone for early-stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269–276PubMedCrossRefGoogle Scholar
  65. 65.
    Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598PubMedCrossRefGoogle Scholar
  66. 66.
    Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • A. M. Mauer

There are no affiliations available

Personalised recommendations